ALTERITY THERAPEUTICS LTD 6-K Analysis & Summary – 3/14/2025

⚠️This is not investment advice.

⚠️ This is an experimental project and this report is for informational purposes only and should not be considered investment advice. Conduct your own thorough research and consult with a qualified financial advisor before making any investment decisions. ⚠️

,

Filing date:

03/14/2025


TLDR:

Alterity Therapeutics Limited is applying for quotation of 161 ordinary fully paid securities on the ASX due to options being exercised.

ELI5:

A small number of new shares in Alterity Therapeutics were created because someone used their option to buy them, and these shares will now be traded on the stock market.


Accession #:

0001213900-25-023838

Published on

Analyst Summary

  • Alterity Therapeutics Limited issued 161 ordinary fully paid securities (ASX code: ATH) as a result of options being exercised.
  • The options were exercised on March 13, 2025, and the corresponding securities were issued on March 14, 2025.
  • The issue price per security was AUD 0.01000000.
  • Following the quotation, the total number of ordinary fully paid securities on issue will be 6,656,848,880.
  • The exercised options were of the type ATHO, expiring on 31-AUG-2026.

⚠️ This is an experimental project and this report is for informational purposes only and should not be considered investment advice. Conduct your own thorough research and consult with a qualified financial advisor before making any investment decisions. ⚠️